cancer-treatment

Documents about cancer-treatment

• Synergistic Effects of Nanomedicine Targeting TNFR2 and DNA Demethylation Inhibitor—An Opportunity for Cancer Treatment#195915HAL (France)
• Stereotactic Radiotherapy Combined With Adebrelimab and TCb (Nab-paclitaxel + Carboplatin) in Neoadjuvant Treatment of TNBC#201760ClinicalTrials.gov
• Impacts of Hurricane-Related Flooding on Time to Initial Cancer Directed Treatment in North Carolina.#214274NCBI PubMed Central
• Racial and ethnic differences in valuation of life expectancy in prostate cancer treatment decision making.#219108NCBI PubMed Central
• The unmet needs of gay and bisexual men following prostate cancer treatment : an integrative literature review#270437The Learning Edge
• Phase II Study of Combined Modality Treatment in Patients With Triple Negative Breast Cancer (TN-BC)#308462IRIS
• Beyond treatment: Parents’ Experiences of Insurance, Legal, and Financial Hardships During Childhood Cancer Survivorship#313374OSF
• Implementation of HER2DX Scores into Treatment Decisions in Early-Stage HER2-Positive Breast Cancer.#315533NCBI PubMed Central
• A Simulation-Based Approach for Inpatient Capacity Management at a Hospital Dedicated for Cancer Treatment.#320535NCBI PubMed Central
• Exploration of Treatment Strategies After Concurrent Chemoradiotherapy for LS-SCLC Guided by MRD#321693ClinicalTrials.gov
• From patient-derived tumor organoids to personalized cancer therapy: advancing treatment for advanced solid tumors.#427834NCBI PubMed Central
• Thinking, Feeling, Choosing: How Affect Is Reflected in Prostate Cancer Treatment Decision Making-A Qualitative Study.#442847NCBI PubMed Central
• Study of Becotatug Vedotin Added to Standard Treatment for Advanced Bile Duct Cancer With EGFR Mutations#451467ClinicalTrials.gov
• Adebrelimab Combined With Bevacizumab and Albumin Paclitaxel in Non-squamous NSCLC After First-line Treatment#467590ClinicalTrials.gov
• Expression of trkB in Human Neuroblastoma in Relation to MYCN Expression and Retinoic Acid Treatment.#685351Lund University Publications
• Incidence, Risk Factor, Treatment and Overall Survival of Locally Recurrent Rectal Cancer#801490ClinicalTrials.gov
• Endoscopic Ultrasound-Guided Chemoablation for the Treatment of Pancreatic Cystic Neoplasms#805724ClinicalTrials.gov
• Oral Pooled Fecal Microbiotherapy (MaaT033) Concomitant to Cemiplimab Versus Best Investigator's Choice in Patients With Resistance to Treatment Due to Antibiotics Uptake With Advanced Non-small Cell Lung Cancer#343849ClinicalTrials.gov
• A Study of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer (G/GEJ) or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)#366615ClinicalTrials.gov
• Quality and Reliability of Lung Cancer Treatment Short Videos on Chinese Social Media: A Cross-Sectional Analysis for Cancer Education Improvement (January 1, 2020-October 30, 2025).#28241NCBI PubMed Central
• Tislelizumab for the Treatment of Recurrent Mismatch Repair Deficient Endometrial Cancer#123442ClinicalTrials.gov
• Assessment of Adebelizumab Combined with Chemotherapy in Concurrent Radiotherapy Versus Sequential Radiotherapy As First-Line Treatment for Extensive-Stage Small Cell Lung Cancer#162477ClinicalTrials.gov
• Tepotinib vs Standard Treatment in Patients With Advanced MET Exon 14 Mutated Non-Small Cell Lung Cancer Previously Treated#303739ClinicalTrials.gov
• BRCA Mutation Status in Triple-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: A Pivotal Role for Treatment Decision-Making#337742IRIS
• 177^Lu-PSMA-617 in Combination With Sipuleucel-T for the Treatment of Metastatic Castration-Resistant Prostate Cancer#349976ClinicalTrials.gov
• Could molecular variations be predictive in right and left colon cancer in different gender and age groups?#358730PLOS
• Get strong to fight childhood cancer : an exercise intervention for children and adolescents undergoing anti-cancer treatment (FORTEe) : rationale and design of a randomized controlled exercise trial#368944The Learning Edge
• Social Determinants of Racial Disparities in Breast Cancer Mortality Among Black and White Women#389899Scholar Commons
• A Study of GLS-010 Plus Platinum-containing Chemotherapy±Bevacizumab as First-line Treatment for Persistent, Recurrent, or Metastatic Cervical Cancer#801562ClinicalTrials.gov
• Low-dose Radiotherapy Combined With Chemotherapy and AK112 as Second-line Treatment in Patients With Advanced G/GEJ Cancer#804665ClinicalTrials.gov
• Intraperitoneal Oxaliplatin and Fluorouracil for the Treatment of Patients With Peritoneal Metastases From Colorectal Cancer#807196ClinicalTrials.gov
• Testing the Addition of Immunotherapy With Hu5F9-G4 (Magrolimab) to the Usual PARP Inhibitor, Olaparib for Treatment of Metastatic or Recurrent Breast or Castrate-Resistant Prostate Cancer With BRCA Mutations#387171ClinicalTrials.gov
• QUILT-2.019: A Study of AMG 655 or AMG 479 in Combination With Gemcitabine for Treatment of Metastatic Pancreatic Cancer#804539ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of Anamorelin HCl for the Treatment of Malignancy Associated Weight Loss and Anorexia in Adult Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)#806597ClinicalTrials.gov
• Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors#300270ClinicalTrials.gov
• Nivolumab After Surgery and Chemotherapy in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer (An ALCHEMIST Treatment Trial)#201767ClinicalTrials.gov
• Adding a Live Biotherapeutic Product (CBM588) to Pembrolizumab for the Treatment of Renal Cell Cancer After Surgery#329521ClinicalTrials.gov
• Ivonescimab combined with chemotherapy for the treatment of metastatic cervical cancer: A case report and literature review#125743Europe PMC
• Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia#162446ClinicalTrials.gov
• “Life after treatment”: what physicians consider important for oral cancer survivors’ quality of life#186677ULRR
• Open radiofrequency ablation as upfront treatment for locally advanced pancreatic cancer: Requiem from a randomized controlled trial#298593IRIS
• BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer#325301ClinicalTrials.gov
• Spatial Fragmentation Combined With Low-dose Radiotherapy for Immunotherapy Combined With Chemotherapy-resistant Locally Advanced or Advanced Non-small Cell Lung Cancer#343825ClinicalTrials.gov
• Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer#405142ClinicalTrials.gov
• Vudalimab for the Treatment of Locally Advanced or Metastatic Anaplastic Thyroid Cancer or Hurthle Cell Thyroid Cancer#426767ClinicalTrials.gov
• LUNAR-4: Effect of Tumor Treating Fields (TTFields) (150 kHz) Concurrent With Pembrolizumab for Treatment of Metastatic Non-small Cell Lung Cancer (NSCLC)#810833ClinicalTrials.gov
• Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection#67856ClinicalTrials.gov
• RP2/RP3 in Combination With Atezolizumab and Bevacizumab for the Treatment of Patients With CRC#125858ClinicalTrials.gov
• Treatment of neuropathic pain in cancer survivors: a scoping review of pharmacological, exercise, and psychosocial interventions.#145814NCBI PubMed Central
• Photobiomodulation in Treatment of Head and Neck Cancer-Related Chronic Lymphedema: A Pilot Randomized Controlled Trial.#165809NCBI PubMed Central